#diabetes

Collection of diabetes news, found 76 news.

Samsung Bioepis' RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea

- Samsung Bioepis Co., Ltd. today announced that Korea’s Ministry of Food and Drug Safety (MFDS) has approved ...

BD Launches New Point-of-Care System for HIV/AIDS Patients

- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology ...

Farmers demand compensation for their narcotics plants

Farmers in Cisarua, in the mountain resort of Puncak, Bogor, said they would destroy their chata edulis plants,locally ...

1.5 Million Premature Cancer Deaths Could be Prevented per Year if Targets Set to Reduce NCDs are Met by 2025

-On World Cancer Day, UICC and International Agency for Research on Cancer (IARC) reveal real-life impact of achieving ...

Berg Pharma Presents Key Findings In Cancer Systems Biology And Mitochondrial Metabolism

-     Berg Pharma, a Boston based pharmaceutical company presented novel data today pertaining to ...

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced

-            - Findings from Two-Year Pivotal Phase III TEMSO Trial ...

Roche and Diagnostica Stago Terminate Partnership

-         Roche Professional Diagnostics and Diagnostica Stago announced today that the ...

More Patients with Type 2 Diabetes Reach HbA[1c] Target with Apidra(R) on top of Lantus(R)

-            - First Randomized Controlled Trial to Show That Basal Plus ...

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

-FDA allows use of investigational new drug for life-threatening indications     Edison ...

Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation

-Designation covers inherited respiratory chain diseases of the mitochondria    Edison Pharmaceuticals, ...

One in five people with diabetes miss up to 15 working hours per month due to low blood sugar

-    Nearly one in five people with diabetes are regularly unable to attend a full day at work due to ...

Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Re

-        - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...

Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Result

- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...

Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA

-Evaluation of Alternative Treatment Strategies Incorporating Platelet Function Testing Recommended    ...

QPS Expands Clinical Trial Services with Acquisition of Qualitix

-        Broadens later stage capabilities and Increases Asian ...